Table 1.

Clinical and Biologic Characteristics of Patients With Indolent SMCD

Patient ID Age/Sex Tissues With MC InfiltrationPB BM Dysplasia % BMMC Tryptase-150Mediator-Related Symptoms Therapy-151
1  26/M  S, BM  N  Dyserithro  0.20  ND  No  None  
67/M  S, BM, B  N  No  0.42  4.2  Pruritus Anti-H1  
        Anti-H2  
30/M  S, BM  Eos  No  0.43  ND  No None  
4  37/F  S, BM  Eos  No  0.24 ND  No  None  
5  67/M  S, BM  Eos  No 0.36  ND  Pruritus  None  
6  51/F  S, BM N  No  0.015  ND  No  None  
7  51/F S, BM, GI, spleen-152 Eos, anemia-153 No  0.02  Pruritus, flush Syncope, abdominal pain Anti-H1 Anti-H2 CS  
     0.09 ND  No  Anti-H1  
        Anti-H2  
        CS  
8  49/M S, BM, B, GI, hepatomegaly  Eos  No  0.49  27 Pruritus, flush Syncope, abdominal pain Anti-H1 Anti-H2 CS Aspirin  
     0.29  6  Pruritus, flush abdominal pain Anti-H1 Anti-H2 CS Aspirin  
9  42/F  S, BM, B Eos  No  0.12  10  Pruritus, flush  Anti-H1 
        Anti-H2  
        CS  
10  33/M  S, BM, GI  N  No 0.15  ND  Pruritus  Anti-H1  
        Anti-H2 
Patient ID Age/Sex Tissues With MC InfiltrationPB BM Dysplasia % BMMC Tryptase-150Mediator-Related Symptoms Therapy-151
1  26/M  S, BM  N  Dyserithro  0.20  ND  No  None  
67/M  S, BM, B  N  No  0.42  4.2  Pruritus Anti-H1  
        Anti-H2  
30/M  S, BM  Eos  No  0.43  ND  No None  
4  37/F  S, BM  Eos  No  0.24 ND  No  None  
5  67/M  S, BM  Eos  No 0.36  ND  Pruritus  None  
6  51/F  S, BM N  No  0.015  ND  No  None  
7  51/F S, BM, GI, spleen-152 Eos, anemia-153 No  0.02  Pruritus, flush Syncope, abdominal pain Anti-H1 Anti-H2 CS  
     0.09 ND  No  Anti-H1  
        Anti-H2  
        CS  
8  49/M S, BM, B, GI, hepatomegaly  Eos  No  0.49  27 Pruritus, flush Syncope, abdominal pain Anti-H1 Anti-H2 CS Aspirin  
     0.29  6  Pruritus, flush abdominal pain Anti-H1 Anti-H2 CS Aspirin  
9  42/F  S, BM, B Eos  No  0.12  10  Pruritus, flush  Anti-H1 
        Anti-H2  
        CS  
10  33/M  S, BM, GI  N  No 0.15  ND  Pruritus  Anti-H1  
        Anti-H2 

Abbreviations: B, bone; BM, bone marrow; BMMC, bone marrow mast cells; GI, gastrointestinal tract; PB, peripheral blood; Eos, eosinophilia; ND, not detected; CS, Cromolyn sodium; N, normal; S, skin.

F0-150

Serum tryptase levels in UI/L.

F0-151

Therapy received at the moment entering the study.

F0-152

Splenomegaly detected by ultrasonography.

F0-153

Iron deficiency anemia.

Close Modal

or Create an Account

Close Modal
Close Modal